News

Filter

Current filters:

MetabolicsSouth America

Helsinn grants anamorelin rights to Stendhal for Latin American countries

29-01-2013

Privately-held Swiss pharmaceutical group Helsinn has granted Latin American specialty company Stendhal…

anamorelinHelsinnLicensingMetabolicsOncologyPharmaceuticalSouth AmericaStendhal

COMPANY SPOTLIGHT

Menarini

Back to top